16 research outputs found

    New Verified Nonindigenous Amphibians and Reptiles in Florida through 2015, with a Summary of More Than 152 Years of Introductions.

    Get PDF
    More nonindigenous species occur in Florida, USA, than any other region worldwide and may threaten many of Florida’s natural resources. The frequency of new reports mandates the need for regular updates. Herein, we use photographic and specimen vouchers in addition to literature records to provide updated information on verified nonindigenous amphibians and reptiles in Florida. Between our most recent summary in 2012 and the end of 2015, 38 additional species are known to have been intercepted (n = 2) or introduced (n = 36). We also update the invasion stage of seven species previously reported from Florida and report that five additional taxa are now established. In total, 191 independent known introductions of 180 herpetofaunal taxa led to the establishment of 63 taxa. This suggests that one in three introduced herpetofaunal species becomes established in Florida. The pet trade represents the most common introduction pathway among these species and a single animal importer in Hollywood, Broward County, is the probable source for introduction of a quarter of all herpetofauna introduced to Florida

    Validation of cutaneous lymphoma international prognostic index (CLIPI) for mycosis fungoides and Sézary syndrome.

    No full text
    We sought to evaluate the performance of the cutaneous lymphoma international prognostic index (CLIPI), a prognostic index for mycosis fungoides (MF), and Sézary syndrome (SS), in our cohort of patients seen at Emory University between 1998 and 2013. Additionally, we examined the prognostic significance of lactate dehydrogenase (LDH), B0a/b, and CD30 status. A total of 390 patients were included in analysis: 78.2% early stage (IA-IIA), 7.2% with SS, 53.1% male, mean age 53.5 years. CLIPI stratified patients into low, intermediate, and high-risk groups for overall survival (OS) and progression free survival (PFS) for early stage patients (p \u3c 0.0001), but was not significant for late stage patients. On multivariable analysis for early stage patients, age \u3e60, plaques, folliculotropic disease was significant for OS and age \u3e60, plaques, N1/Nx was significant for PFS. In the overall cohort, CD30+, elevated LDH, and B0b were significant for worse OS and PFS
    corecore